Código QR (código de barras bidimensional)

Effectiveness of mass dengue vaccination with CYD-TDV (Dengvaxia®) in the state of Paraná, Brazil: integrating case-cohort and case-control designsResearch in context

Summary: Background: CYD-TDV (Dengvaxia®) was the first dengue vaccine approved, launched in Brazil in 2015 for individuals aged 9–44 years. We aimed to estimate the effectiveness of CYD-TDV in preventing symptomatic dengue cases during a campaign targeting individuals aged 15–27 years in selected...

ver descrição completa

Na minha lista:
Principais autores: Fredi Alexander Diaz-Quijano, Denise Siqueira de Carvalho, Sonia Mara Raboni, Silvia Emiko Shimakura, Angela Maron de Mello, Magda Clara Vieira da Costa-Ribeiro, Lineu Silva, Marilene da Cruz Magalhães Buffon, Eliane Mara Cesario Pereira Maluf, Gabriel Graeff, Gustavo Almeida, Clara Preto, Karin Regina Luhm
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2024-07-01
coleção:The Lancet Regional Health. Americas
Assuntos:
Dengue
Brazil
Vaccine effectiveness
CYD-TDV
Public health surveillance
Acesso em linha:http://www.sciencedirect.com/science/article/pii/S2667193X24001042
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados